1. Home
  2. NWG vs EW Comparison

NWG vs EW Comparison

Compare NWG & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWG
  • EW
  • Stock Information
  • Founded
  • NWG 1727
  • EW 1958
  • Country
  • NWG United Kingdom
  • EW United States
  • Employees
  • NWG N/A
  • EW N/A
  • Industry
  • NWG Commercial Banks
  • EW Industrial Specialties
  • Sector
  • NWG Finance
  • EW Health Care
  • Exchange
  • NWG Nasdaq
  • EW Nasdaq
  • Market Cap
  • NWG 39.0B
  • EW 39.3B
  • IPO Year
  • NWG N/A
  • EW 2000
  • Fundamental
  • Price
  • NWG $10.22
  • EW $70.38
  • Analyst Decision
  • NWG Strong Buy
  • EW Buy
  • Analyst Count
  • NWG 1
  • EW 21
  • Target Price
  • NWG N/A
  • EW $76.60
  • AVG Volume (30 Days)
  • NWG 2.5M
  • EW 5.3M
  • Earning Date
  • NWG 10-25-2024
  • EW 10-24-2024
  • Dividend Yield
  • NWG 5.70%
  • EW N/A
  • EPS Growth
  • NWG 10.87
  • EW 193.69
  • EPS
  • NWG 0.70
  • EW 6.89
  • Revenue
  • NWG $18,754,858,592.00
  • EW $6,314,900,000.00
  • Revenue This Year
  • NWG N/A
  • EW $0.34
  • Revenue Next Year
  • NWG $4.61
  • EW $1.64
  • P/E Ratio
  • NWG $6.72
  • EW $10.26
  • Revenue Growth
  • NWG N/A
  • EW 24.02
  • 52 Week Low
  • NWG $5.16
  • EW $58.93
  • 52 Week High
  • NWG $10.32
  • EW $96.12
  • Technical
  • Relative Strength Index (RSI)
  • NWG 62.60
  • EW 60.87
  • Support Level
  • NWG $9.91
  • EW $65.31
  • Resistance Level
  • NWG $10.17
  • EW $71.08
  • Average True Range (ATR)
  • NWG 0.14
  • EW 1.84
  • MACD
  • NWG -0.00
  • EW 0.43
  • Stochastic Oscillator
  • NWG 75.58
  • EW 88.69

About NWG NatWest Group plc (each representing two (2))

NatWest Group derives around 90% of its total income from the United Kingdom. The bank operates a retail, commercial, and private bank in the U.K., offering clients lending and payment services as well as asset management services.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.

Share on Social Networks: